Performance of an Artificial Intelligence Foundation Model for Prostate Radiotherapy Segmentation Patients who underwent initial consultation in a thoracic clinic between January 2019 and July 2023 ...
SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results